Oh oh, Ad Blocker gedecteerd!
Het lijkt erop dat je een Ad Blocker gebruikt op De Beleggersgids. Gelieve de Ad Blocker uit te schakelen en advertenties toe te laten op onze website. De Beleggersgids is afhankelijk van inkomsten uit advertenties om jou alle artikels gratis te brengen. Gun je ons geen inkomsten? Ga verder

Financial results in line with forecasts for the 2016 financial year

  • ▪  Net current result (excluding IAS 39 impact) - Group share: 2.86 EUR per share (compared to 3.35 EUR at 30.06.2015) – Impact of some non-recurrent elements (-0.25 EUR/share) and the increase in the number of shares entitled to share in the results (-0.35 EUR/share)

  • ▪  Result on the portfolio: 0.58 EUR per share (compared to -0.38 EUR at 30.06.2015)

  • ▪  Net result - Group share: 1.65 EUR per share (compared to 3.04 EUR at 30.06.2015)

  • ▪  Forecast confirmation of the net current result (excluding IAS 39 impact) – Group share for the 2016 financial year : 6.19 EUR per share

  • ▪  Confirmation of the gross dividend forecast for the 2016 financial year, payable in 2017: 5.50 EUR per ordinary share

    Strong operating performances:

  • ▪  Stable occupancy rate: 94.9 %

  • ▪  Particularly long residual lease length: 10.2 years

  • ▪  Gross rental revenues up by 0.2 % over the past 12 months (+0.5 % on a like-for-like basis)

  • ▪  Portfolio value up by 3.2 % over the past six months (+0.4 % on a like-for-like basis)

  • ▪  Resilient EPRA Net Asset Value: 94.61 EUR per share (93.34 EUR at 31.12.2015)

    Continuation of the investment programme:

  • ▪  Acquisition of an office building in Brussels for 31 million EUR

  • ▪  Acquisition of two healthcare assets in Germany for 39 million EUR1

  • ▪  Signature of an agreement for the renovation and extension of three healthcare assets in Belgium and France for 16 million EUR

  • ▪  Investments realised since the May 2015 capital increase: 171 million EUR, of which 120 million EUR in healthcare real estate and 47 million EUR in office buildings

  • ▪  Committed investment pipeline for the 01.07.2016 – 31.12.2018 period: 308 million EUR, of which 117 million EUR in healthcare real estate and 179 million EUR in office buildings

    Conditional sale of the Souverain/Vorst 25 office building (Decentralised Brussels)

  • ▪  Ownership transfer at the earliest at the departure of the current tenant AXA (August 2017), and subject to obtaining the necessary permits and authorisations from the public authorities

  • ▪  Reconversion by Cofinimmo of the neighbouring Souverain/Vorst 23 building into residential units

326 lezers bereikt
De Beleggersgids Redactie

1. Like onze Facebook pagina
2. Volg ons op Twitter
3. Schrijf je in op onze nieuwsbrieven
4. Plaats een berichtje op ons forum

De Beleggersgids

Heldere en begrijpbare kennis, inzichten, inspiratie en nieuws over investeren in vastgoed, beleggingen, investeringen en geld.

Al 7.785 abonnees en groeiend

Top
×

De interessantste artikels wekelijks in je mailbox? Schrijf je in!

Ik ga akkoord met de voorwaarden
×

De interessantste artikels in je mailbox.

Ik ga akkoord met de voorwaarden